Elizabeth M. Jaffee

Bloomberg (United States)

Full Professor(heuristic)

Cancer Immunotherapy and Biomarkers · Oncology

Compare more Oncology professors.

h-index112
i10-index340
Publications1,439
Citations57,171

Grants

7 total · 1 active

NIH #R01CA293602

Targeting HMGA1 Tumor-Stromal Networks in Pancreatic Carcinogenesis

Active
Amount
$1M–$2M
Period
2024-07-01 → 2029-06-30
PIs
2

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #P01CA247886

Transforming Human Pancreatic Cancer Into An Immunologic Disease

Amount
$2M–$3M
Period
2021-06-01 → 2026-05-31
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #R01CA197296

Reprogramming the pancreatic tumor microenvironment with immunotherapy

Amount
$500K–$600K
Period
2015-07-21 → 2021-05-31
PIs
2

Awarded at JOHNS HOPKINS UNIVERSITY

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

7 total · 1 active

NIH #R01CA293602

Targeting HMGA1 Tumor-Stromal Networks in Pancreatic Carcinogenesis

Active
Amount
$1M–$2M
Period
2024-07-01 → 2029-06-30
PIs
2

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #P01CA247886

Transforming Human Pancreatic Cancer Into An Immunologic Disease

Amount
$2M–$3M
Period
2021-06-01 → 2026-05-31
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #R01CA197296

Reprogramming the pancreatic tumor microenvironment with immunotherapy

Amount
$500K–$600K
Period
2015-07-21 → 2021-05-31
PIs
2

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #R01CA184926

(PQB-3) Driver gene-induced inflammation in pancreatic cancer development

Amount
$700K–$800K
Period
2014-05-01 → 2018-04-30
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #P30CA006973

CELL PROCESSING AND GENE THERAPY

Amount
$400K–$500K
Period
— → 2016-04-30
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #P50CA062924

Project 4 :Using TME genetics and immunobiology to drive combination immunotherapies

Amount
$400K–$500K
Period
— → —
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #P50CA103175

Developmental Fund

Amount
$100K–$200K
Period
— → —
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

Recent Public Signals

  1. New paper: Peripheral Th17 immune signature associates with excellent response to anti-PD1/anti-PD-L1 therapy across solid tumors (Cancer Immunology Research)2026-06-26
  2. New NIH award: Targeting HMGA1 Tumor-Stromal Networks in Pancreatic Carcinogenesis2024-07-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0003-3841-6549

Professor Insights

Career Trajectory